Ontology highlight
ABSTRACT:
SUBMITTER: Kaur B
PROVIDER: S-EPMC4233127 | biostudies-literature | 2012 Jul
REPOSITORIES: biostudies-literature
Kaur Balveen B Chiocca E Antonio EA Cripe Timothy P TP
Current pharmaceutical biotechnology 20120701 9
Oncolytic virotherapy with mutants derived from Herpes simplex virus (HSV) type 1 exhibit significant antitumor effects in preclinical models. Several mutants have now been tested in clinical trials for a variety of cancer types, and all have been found to be safe. While there have been hints of antitumor efficacy with prolonged survival in some cases compared with historical controls, dramatic responses have been elusive. We review the clinical experience published to date and discuss some of t ...[more]